The two T-cell subsets were shown to be important in determining the outcome of certain parasitic infections in mice. The genetic determined resistance against infection with Leishmania major seems to be associated with Thl responses, whereas fatal leishmaniasis in mice is associated with Th2 responses.3 Schistosoma mansoni infection in mice is associated with a shift to Th2 responses. Importantly, infection with S mansoni induces Th2 responses not only to the parasite itself, but also to nonparasite antigens4
Yersiniu enteroliticu induced reactive arthritis."' In contrast, in atopic individuals"'," and in the conjunctiva of patients with vernal conjunctivitis,'* Th2-like T cells could be demonstrated. In human leishmaniasis, the distinction in the cytokine secretion by the T cells of the patients, Thl versus ThZlike, is reflected by different clinical features, localized versus chronic, and destructive leishmaniasis. '' Before the loss of CD4+ T cells in later stages of infection, immunodeficiency caused by human immunodeficiency virus (HIV) infection is characterized by functional defects of capacities ascribed to Thl cells that are observed in early infection. Proliferation of T cells in response to ligation of the T-cell receptor (TCR) CD3 complex is impairedl4-I6 and IL-2 production decreased."~" Furthermore, antigen-induced IFN-y production19 and DTH reactions are decreased.20.2' Clinical symptoms associated with a relative dominance of Th2-mediated responses have been described in HIV-infected individuals and include eosinophilia,** elevation of serum IgE levels" and allergic manifestation^.^^, ^^ Here, we investigated whether HIV infection might be associated with a change in Th cytokine-secretion patterns.
To study the potential of T cells from HIV-infected individuals to secrete lymphokines, we investigated the type of T cells that could be cloned during the asymptomatic phase of the infection.
MATERIALS AND METHODS

Subjects.
Peripheral blood from both asymptomatic HIV-infected subjects and noninfected controls enrolled in the Amsterdam cohort study on HIV infection in homosexual menZh was used for isolation of cells. All were in the asymptomatic phase of infection (Centers for Disease Control, class 11) and did not receive medication. For all but one subject, the date of HIV-I antibody seroconversion was known.
Cells from a seronegative participant of the cohort and cells from subjects no. I160 and 0082, obtained before infection with HIV and stored by cryopreservation, were used as controls. None of the subjects had allergic or atopic manifestations before infection with HIV. Table I summarizes the characteristics of the subjects at the moment cells were taken for cloning. In follow-up, it showed that subject no. 0545 developed a syncynium-inducing virus variant2' and had 0.31 X lO'L 0 4 ' cells at 15 months from the time point studied here. Apart from idiopathic dermatologic manifestations, he remained asymptomatic until then. Subject no. 1160 still had normal CD4+ cell counts (0.45 x IO'L) at 40 months after the moment studied and remained asymptomatic. Subject no. 6032 suffered from eczema and 18 months after the date from which cells were used, AIDS was diagnosed because of a clinical manifest infection with M. tuberculosis. The subject responded with hypersensitivity reactions to the treatment he received. Subject no. 0082, from which cells from three different time points were used to obtain T-cell clones (TCC), had eczema 49 months after seroconversion and has, since the last time point, dropped in CD4+ cell counts (0.29 X lo9/ L at 75 months after seroconversion).
Cell sorting. Peripheral blood mononuclear cells (PBMC) were isolated from heparinized blood by Ficoll density gradient centrifugation and cryopreserved. After thawing the cells, they were stained with fluorescein isothiocyanate (FITC) labeled Leu-2A (CD& Becton Dickinson, Sunnyvale, CA) and phycoerythrin (PE)-labeled 2H4 (CD45RA, Coulter, Hialeah, FL). After washings, cells were purified for CD8-CD45RA-T cells by cell sorting (FACStar, Becton Dickinson).
Generation of T-cell clones. Purified CDKCD45RA-T cells were cultured under limiting dilution conditions (0.3 cells/well) in the presence of phytohemagglutinin (PHA) ( I pg/mL, Wellcome Research Laboratories, Beckenham, England) and y-irradiated (3,000 rad) allogenic PBMC (106/mL) in Iscove's modified Dulbec-CO's medium (IMDM) supplemented with 10% human pooled serum, 20 U/mL rIL-2 (Hoffman-La Roche, Nutley, NJ) and antibiotics." TCC from each donor were generated with similar cloning efficiency and passaged weekly by culturing equal numbers of either clone (0.3 X 106/mL) with PHA, feeders, and IL-2 as described above. Clones were analyzed for the expression of CD4+ and the absence of CD8+ by fluorescence-activated cell sorter (FACS) analysis using standard procedures. Functional studies were performed 7 days after restimulation.
Functional studies. 0.25-1 X IOb/mL cells were stimulated with phorbol myristate acetate (PMA) (1 ng/mL) and CD3 monoclonal antibody (MoAb) (CLB-T3/4.E, 5 pg/mL) in IMDM supplemented with 10% fetal calf serum (FCS), 7 days after the last restimulation. At this time, no viable feeder cells producing cytokines were present, and the clones did not produce detectable levels of cytokines spontaneously. Supernatants were collected after 24 hours to measure IL-2 and at 72 hours for IL-4, IL-5, IL-IO, and IFN-y measurement, which in our hands were optimal time intervals from the production of these cytokines. Supernatants were stored in aliquots at -20°C and thawed once before analysis. IL-2 concentration in the supernatant was measured in a bioassay using the IL-2 dependent CTLL-2 line." IL-4 production was assayed in an IL-4-specific enzymelinked immunosorbent assay (ELISA), generously provided by Dr T. van der Pouw-Kraan (Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands).'" IL-5," IL-10?2 and IFN-7" production were determined by ELISA, developed and kindly provided by DNAX Institute (Palo Alto, CA). Cytokine production was measured in supernatants from three separate experiments. As a control for the capacity of the clones to respond to the given stimulus, proliferation was measured by ['H]-thymidine incorporation.
RESULTS
Increased IL-4 production by T-cell clones from HIVinfected subjects. We characterized TCC derived from CD8-CD45RA-T cells from asymptomatic HIV-infected subjects and seronegative homosexual men as controls. The randomly generated CD4' TCC were analyzed for their cytokine secretion on stimulation with PMA and CD3 MoAb. Compared with two controls, PBMC from HIV-infected individuals yielded a decreased percentage of IFN-?, producing TCC, whereas the percentage of IL-4 producing clones was increased ( Table 2) .
Despite decreases in percentages of TCC producing IF'N-7 ( Table 2) , mean IFN-7 production by clones from W-infected subjects was not different from controls (Fig 1B) . Importantly, mean IL-4 production by TCC from HN-infected men as a group was significantly increased compared with TCC from controls ( Fig 1C) . When analyzed per individual, clones from all three seropositive subjects had increased IL-4 production, although in one case (no. 0545) this increase was not significant. L-5 production paralleled IL-4 production as can be clearly observed in Fig 1D; however, the differences were not significant. The percentage of K-2, IL-5 and E -l 0 producing TCC A total of 0.25 x 106/mL clone cells were stimulated with PMA and CD3 MoAb 7 days after the last restirnulation. At day 1 (IL-2) and day 3 (IFN-7, IL-4, IL-5, and IL-10). supernatants were collected and cytokines were measured.
*Data are percentages of clones producing indicated cytokine above two times the background level of the assay. Clones from two H P -(0177 and 1160) and three HIV+ (0545, 1160, and 6032) subjects are displayed per subject and as a group (HIV-and HIV+). Seventythree clones from two seronegative individuals are displayed as seronegative controls (HIV-). Each clone was analyzed in three separate experiments.
t From subject no. 1160, TCC were obtained 6 months before (-6) and 27 months after (+27) seroconversion.
$ P < ,0005. For varied alike in infected and noninfected individuals ( Table 2) . Although the percentage of L -2 producing TCC of subject no. 0545 was significantly higher (Table  2) , the mean IL-2 production by the clones was comparable to HN-negative controls because the quantity of L 2 produced by TCC of this subject was relatively low (Fig 1A) . Mean L 1 0 production was increased in the clones from subject no.
6032. It is of interest to note that in this subject, TCC also produced high amounts of IL-4 and IL-5.
We grouped clones according to their Thl (IL-2 and/or IFN-y), Th2 (IL-4 and/or IL-5) or Tho phenotype (clones producing a combination of Thl and Th2 cytokines) (Fig 2) . IL-10 was not used as a discriminatory cytokine. Although Changes in cytokine secretion in fwo subjects followed over seroconversion. Interindividual differences in the cytokine secretion patterns might influence the comparison of TCC from HIV-infected subjects with controls. For this reason, we compared TCC from the same subject obtained before and after HIV infection by taking the opportunity to use cryopreserved patient material.
As displayed in Table 2 , from subject no. 1160, TCC were generated from cells stored 6 months before and 27 months after seroconversion. Indeed, when TCC are compared within this subject, the percentage of IL-2 and IFN-y producing clones decreases on HIV infection, while the percentage of IL-4 producing clones significantly increases (Table 2) . In addition, the mean IL-4 production of the TCC obtained after HIV infection increases (HIV-: 0.06 ng/mL to HIV+: 0.28 ng/mL; Fig 3) .
In a second set of experiments, we generated TCC from CD8-CD45RA-cells from cryopreserved material from one subject obtained 8 months before and 33 and 51 months after seroconversion and were able to analyze the temporal changes of TCC characteristics in HIV infection. Also in this subject, the percentage of TCC producing IFN-y decreased in time, while the percentage of IL-4 and IL-5 producing TCC was increased in the last time point studied (Table 3) . Mean IFN-y production clearly decreased upon HIV infection (mean 119 ng/mL before seroconversion and 68 and 67 ng/mL after seroconversion, P < .05 at the last time-point in Mann-Whitney test , Fig 2) , while IL-4 production increases in time (mean 0.14, 0.31 and 0.68 ng/rnL, respectively; Fig 3) . IL-2, IL-5, and IL-10 production per TCC showed a small decrease in the last time point.
DISCUSSION
Our findings demonstrate that on HIV infection, T cells cloned from CD4+ memory cells, show changes in their cytokine profiles. Most marked was the consistently observed increase in IL-4 production after HIV infection, often paralleled by increased IL-5 and decreased IFN-7 production, resulting in an increase in Tho clones. Importantly, we were able to compare TCC from two HIV-infected subjects with clones obtained from the same subjects before HIV 4265 infection. We demonstrated that the cytokine secretion pattern from TCC from two subjects changes on HIV infection to a Tho pattern, excluding interindividual differences as a cause for the observations.
The change in cytokine secretion patterns was not observed in all subjects tested. We cannot correlate the Tho shift with a specific stage of infection, but our results are suggestive for a relation with the stage of infection, because one subject followed over seroconversion displayed a gradual change in cytokine patterns. These observations are compatible with the findings from Clerici et aL3' They studied IL-2 production induced by recall antigen and mitogen-induced IL-4 production by PBMC from HIV-infected individuals. In the early phase of infection, both cytokines are produced at comparable levels as in negative controls. However, at later time points, IL-4 production increases and is accompanied by a decreased IL-2 production, supporting a shift from Thl to Th2 type cells in asymptomatic HIV infection. In the more progressive stage of infection, both IL-2 and IL-4 production are d e c r e a~e d .~~ So far, analyses of human TCC have suggested Thl or Th2 polarization in several pathological conditions.5~6~'~1"~'2 In studies revealing Thl responses to M leprae and Th2 cells in the conjunctiva of patients with vernal conjunctivitis, discrimination between the two subsets was mainly based on quantitative differences in IL-4 and IFN-y secretion, rather than qualitatively different clone^.^^'^ In studies in atopic patients or Yersinia-induced reactive arthritis, production of IL-4 or IL-5 was considered discriminatory for Th2 IL-2 in one study was reported as discriminatory.' Thus, the extent of changes in cytokine secretion patterns we observed in HIV-infected subjects are comparable to those observed in other pathologic conditions in humans.
By analyzing TCC, Maggi et a13' demonstrated a reduced production of IL-2 and IFN-y in acquired immunodeficiency syndrome (AIDS) patients. Recently, the same group generated a large panel of CD4' TCC specific for purified protein derivative (PPD) or T gondii, which are in vivo activated memory cells, and have observed a significant increase in the production of Th2 cytokines by clones generated from HIV-infected individuals, resulting in an increased percentage of Tho type clone^.^' At the same time Graziosi et a14" concluded from mRNA levels in peripheral blood T cells and lymph nodes that no change in cytokine secretion can be observed on HIV infection. This might be explained by the report from Maggi et al, in which TCC, randomly generated and not specifically from the memory T-cell population, do not show a shift towards Tho, in agreement with their findings in bulk PBMC cultures.3y
The mechanism by which HIV infection leads to a change in cytokine secretion of CD4' T cells remains to be elucidated. Allergen-or parasite-induced changes in cytokine profile in the individuals studied can be ruled out, because none of the patients had evidence of atopic manifestations before HIV infection or experienced clinically manifest parasitic infections Cytokine production by TCC from subject no. 0082, obtained before and after HIV infaction. TCC obtained from one subject 8 months before and 33 and 51 months after HIV seroconversion were stimulated with PMA and CD3 MoAb, and cytokine production was measured as described in the legend to Table 3 . Each dot represents mean cytokine production of one clone, bars represent mean of the group of clones. 
